These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38309553)

  • 1. Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?
    Manoharan SD; Abdul Hamid H; Md Hashim NF; Cheema MS; Chiroma SM; Mustapha M; Mehat MZ
    Brain Res; 2024 Apr; 1829():148793. PubMed ID: 38309553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.
    Zhang H; Wang X; Xu P; Ji X; Chi T; Liu P; Zou L
    J Physiol Sci; 2020 Jun; 70(1):29. PubMed ID: 32517647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3β and its Inhibitors in Alzheimer's Disease: A Recent Update.
    Chauhan N; Paliwal S; Jain S; Verma K; Paliwal S; Sharma S
    Mini Rev Med Chem; 2022; 22(22):2881-2895. PubMed ID: 35450523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A.
    Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G
    Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src.
    Yao XQ; Zhang XX; Yin YY; Liu B; Luo DJ; Liu D; Chen NN; Ni ZF; Wang X; Wang Q; Wang JZ; Liu GP
    Biochem J; 2011 Jul; 437(2):335-44. PubMed ID: 21554241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.
    Qian W; Shi J; Yin X; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
    J Alzheimers Dis; 2010; 19(4):1221-9. PubMed ID: 20308788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
    Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of PKCε Activation and PTP1B Inhibition Effectively Suppresses Aβ-Induced GSK-3β Activation and Tau Phosphorylation.
    Kanno T; Tsuchiya A; Tanaka A; Nishizaki T
    Mol Neurobiol; 2016 Sep; 53(7):4787-97. PubMed ID: 26328540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease.
    Sharma N; Tramutola A; Lanzillotta C; Arena A; Blarzino C; Cassano T; Butterfield DA; Di Domenico F; Perluigi M; Barone E
    Neurobiol Dis; 2019 May; 125():176-189. PubMed ID: 30738142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation.
    Wang Y; Yang R; Gu J; Yin X; Jin N; Xie S; Wang Y; Chang H; Qian W; Shi J; Iqbal K; Gong CX; Cheng C; Liu F
    Neurobiol Aging; 2015 Jan; 36(1):188-200. PubMed ID: 25219467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of donepezil against Aβ42-induced neuronal toxicity are mediated through not only enhancing PP2A activity but also regulating GSK-3β and nAChRs activity.
    Noh MY; Koh SH; Kim SM; Maurice T; Ku SK; Kim SH
    J Neurochem; 2013 Nov; 127(4):562-74. PubMed ID: 23711227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toluidine blue O attenuates tau phosphorylation in N2a-APPSwe cells.
    Onder S; Biberoglu K; Yuksel M; Tacal O
    Chem Biol Interact; 2022 Oct; 366():110126. PubMed ID: 36027949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.
    Arif M; Wei J; Zhang Q; Liu F; Basurto-Islas G; Grundke-Iqbal I; Iqbal K
    J Biol Chem; 2014 Oct; 289(40):27677-91. PubMed ID: 25128526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-terminal truncation of GSK-3β enhances its dephosphorylation by PP2A.
    Jin N; Wu Y; Xu W; Gong CX; Iqbal K; Liu F
    FEBS Lett; 2017 Apr; 591(7):1053-1063. PubMed ID: 28267204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcystin-Leucine-Arginine Induces Tau Pathology Through Bα Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3β Phosphorylation.
    Zhang Y; Zhang J; Wang E; Qian W; Fan Y; Feng Y; Yin H; Li Y; Wang Y; Yuan T
    Toxicol Sci; 2018 Apr; 162(2):475-487. PubMed ID: 29228318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulatory GSK-3β: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease.
    Kumari S; Singh A; Singh AK; Yadav Y; Bajpai S; Kumar P; Upadhyay AD; Shekhar S; Dwivedi S; Dey AB; Dey S
    J Alzheimers Dis; 2022; 85(1):249-260. PubMed ID: 34776454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early glycogen synthase kinase-3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathway.
    Majd S; Power JH; Koblar SA; Grantham HJ
    Eur J Neurosci; 2016 Aug; 44(3):1987-97. PubMed ID: 27177932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease.
    Farr SA; Ripley JL; Sultana R; Zhang Z; Niehoff ML; Platt TL; Murphy MP; Morley JE; Kumar V; Butterfield DA
    Free Radic Biol Med; 2014 Feb; 67():387-95. PubMed ID: 24355211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.